Recent work has identified CD44 as the most common marker for cancer stem cells (CSCs) in several human cancers, including breast19, gastric20, colon21, prostate22, colorectal23, pancreatic24, and head and neck squamous cell carcinomas25. Here, CD44 is linked to cancer.